Soy Products May Help Lower Blood Pressure, Especially in African-Americans
COMPOUND IN SOY PRODUCTS MAY HELP LOWER BLOOD PRESSURE
Benefit among African Americans of particular note
CHICAGO (March 25, 2012) — Soy-based food products have taken grocery store shelves by storm, and the benefits of soy are steadily beginning to emerge. Eating foods that contain isoflavones – a key compound in soy milk, tofu, green tea and even peanuts – every day may help young adults lower their blood pressure. Moreover, and for the first time, there appears to be a particular benefit for African Americans, who have hypertension prevalence rates near 42 percent, according to research presented today at the American College of Cardiology’s 61st Annual Scientific Session. The Scientific Session, the premier cardiovascular medical meeting, brings cardiovascular professionals together to further advances in the field.
“What’s unique about this study is that the results are very applicable to the general population. Our results strongly suggest a blood pressure benefit for moderate amounts of dietary isoflavone intake in young black and white adults,” said Safiya Richardson, a graduating medical student at Columbia University’s College of Physicians and Surgeons and the study’s lead investigator. “Our study is the first to show a benefit in African Americans, who have a higher incidence of high blood pressure, with an earlier onset and more severe end-organ damage.”
Compared to those consuming less than 0.33 mg of isoflavones per day, those reporting the most isoflavone intake (more than 2.5 mg per day) had a significantly lower systolic blood pressure (–5.5 mmHg lower on average). To help put this into context, an 8 ounce glass of soy milk has about 22 mg of isoflavones, and 100 g of roasted soybeans have as much as 130 mg.
“This could mean that consuming soy protein, for example, in combination with a DASH diet – one that is high in fruits and vegetables, low-fat dairy and whole grains – could lead to as much as a 10 mmHg drop in systolic blood pressure for pre-hypertensives, greatly improving their chances of not progressing to hypertension,” said Richardson. “Any dietary or lifestyle modification people can easily make that doesn’t require a daily medication is exciting, especially considering recent figures estimating that only about one third of American hypertensives have their blood pressure under control.”
Isoflavones are thought to work by increasing the production of enzymes that create nitric oxide (NO), a substance that helps to dilate or widen blood vessels, thereby reducing the pressure created by blood against the vessel walls. Richardson said this mechanism may partially explain why the study was able to find an association with smaller amounts of isoflavone intake than examined previously. The relatively pronounced results in the overall biracial cohort may be driven by a more intense effect of isoflavones in African Americans, Richardson said. This is because endothelial dysfunction, a condition in which the
– more –
blood vessels have a hard time either producing or using NO, plays a bigger role in hypertension in African Americans than it does in whites.
“It’s possible that these foods may help compensate for this,” she said. “Based on our results and those of previous studies, we would encourage the average adult to consider including moderate amounts of soy products in a healthy, well-balanced diet to reduce the chances of developing high blood pressure. For people with hypertension, it’s important that they talk with their doctor about isoflavones as a possible addition to a low sodium DASH diet that could reduce the need for medication.”
Richardson added that different soy products have different concentrations of isoflavones, so it is important for consumers to do their homework.
Researchers analyzed data from year-20 of the Coronary Artery Risk Development in Young Adults (CARDIA) study, which is an NIH-funded study created to examine the development and determinants of cardiovascular disease. This study began in 1985 with 5,115 African American and white Americans aged 18-30 years old who have been followed and reexamined at various intervals. Year-20 was the first year that participants completed an extensive dietary survey. Multivariable linear regression models evaluated the relation between daily isoflavone intake and systolic BP (SBP) after dividing patients across quartiles according to self-reported isoflavone intake. Even after controlling for age, sex, BMI, smoking, alcohol, physical activity and total caloric intake, the relationship between daily isoflavones and lower systolic blood pressure remained.
Richardson says this study helps lay the groundwork for randomized controlled trials to help better understand the association between isoflavones and blood pressure. She reports no conflicts of interest.
Richardson will be available to the media on Sunday, March 25 at 1 p.m. in Media Room #1, McCormick Place North Level 1, Hall C1.
Richardson will present the study “Dietary Isoflavone Intake is Associated with Lower Systolic Blood Pressure: the Coronary Artery Risk Development in Young Adults (CARDIA) Study” on Sunday, March 25, 2012 at 9:30 a.m. in McCormick Place South, Hall A.
Beth Casteel 240.328.4549 firstname.lastname@example.org
Larry Farnsworth 703.489.9633 email@example.com
ACC.12 News Room 312.808.2000
About the American College of Cardiology
The American College of Cardiology (www.cardiosource.org) is a 40,000-member nonprofit medical society comprised of physicians, surgeons, nurses, physician assistants, pharmacists and practice managers. The College transforms cardiovascular care and improves heart health as it supports and advocates for quality improvement, patient-centered care, payment innovation and professionalism. The ACC bestows credentials upon cardiovascular specialists who meet its stringent qualifications and leads the formulation of health policy, standards and guidelines. It provides professional education, supports and disseminates cardiovascular research, and operates national registries to measure and promote quality.
The ACC’s Annual Scientific Session brings together cardiologists and cardiovascular specialists from around the world each year to share the newest discoveries in treatment and prevention.